Wednesday, September 22, 2021 2:51:43 PM
New York Yankees and Duke Basketball
Recent VRDN News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 10:31:38 AM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 07/03/2024 12:00:00 PM
- Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease • Business Wire • 06/11/2024 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/10/2024 12:05:27 PM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/06/2024 08:01:00 PM
- Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences • Business Wire • 05/31/2024 12:00:00 PM
- Viridian Therapeutics to Participate in Upcoming May Investor Conferences • Business Wire • 05/10/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:51:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:09:01 AM
- Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results • Business Wire • 05/08/2024 11:00:00 AM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/03/2024 12:00:00 PM
- Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024 • Business Wire • 04/29/2024 12:00:00 PM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/04/2024 08:01:00 PM
- Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/06/2024 09:01:00 PM
- Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference • Business Wire • 03/05/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/28/2024 09:10:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:07:35 PM
- Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/27/2024 09:01:00 PM
- Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer • Business Wire • 02/16/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 01:28:55 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:08:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:05:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:05:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:01:13 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM